Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

Oral tofacitinib successfully treated total body hair loss in one patient.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Atopic dermatitis needs personalized treatment using various therapies, starting with topical corticosteroids.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

JAK inhibitors effectively treat Lichen Planopilaris, but long-term safety is uncertain.

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Oil A formulation with Baricitinib shows promise for treating alopecia areata by promoting hair growth.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Electric stimulation at 448 kHz can promote hair growth by enhancing cell activity in hair follicles.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

New understanding and treatments for hair loss are improving, but more research is needed.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Organoids and hair-on-chip technologies show promise for hair regeneration but face clinical challenges.

Broussonetia papyrifera extract helps hair growth by regulating specific proteins.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Skin pigmentation varies due to genetics, UV exposure, and medications, with treatments available but requiring medical advice.